|Guggenheim Partners||Adnan Butt|
|Leerink Partners||Ami Fadia|
|Needham & Company||Alan Carr, Ph.D., CFA|
|RBC Capital Markets||Gregory Renza, M.D.|
Iterum Therapeutics plc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Iterum Therapeutics plc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Iterum Therapeutics plc or its management. Iterum Therapeutics plc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.